Based on these premises, we generated tumorspheres from the HCT116 CRC cell line and its SMYD3-KO counterpart to evaluate the effect of SMYD3 ablation or pharmacological inhibition on cancer cell proliferation and chemotherapy response in these more complex systems. The gene discussed is SMYD3; the disease is colorectal carcinoma.